Stocks › ATRC
AtriCure, Inc. (ATRC) stock analysis
BUY 39% confidence · analysed Oct 13, 2026
On Oct 13, 2026, our model rated AtriCure, Inc. (ATRC) BUY with 39% confidence at a price of $57.28. That means most of the technical, fundamental, money-flow and news signals point to upside.
Technical picture
The 14-day RSI is 46, close to the neutral 50 line, so momentum is balanced.
MACD is below its signal line, so short-term momentum is pointing down.
The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.
Volume is only 0.4x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure shows a bullish break of structure (BOS): price broke a recent swing high in the direction of the trend, which usually signals trend continuation.
The most recent swing high is $43.18 and the swing low is $25.36; traders often treat these as resistance and support.
Price is sitting in a bearish order block, a zone where large sellers stepped in before, so upside may stall here.
Fundamentals
The PEG ratio is 10.00, which looks expensive relative to its growth.
The company reports a profit margin of 1.9% and revenue growth of +12.8%.
In its latest quarter it earned $0.18 per share, which beat the $0.02 analysts expected, with revenue +12.8% year over year.
Wall Street's average rating is 1.9 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $54.89.
The next earnings report is expected around Oct 27, 2026; prices often move sharply around earnings.
Trade plan from the model
The model's long / bullish plan uses an entry near $56.44, a target of $64.01 (+13.4%) and a stop-loss at $51.24 (-9.2%).
That is a reward-to-risk ratio of about 1.5 to 1: the potential gain is not much bigger than the loss, so the setup is marginal.
The plan has a time limit: reassess by Oct 26, 2026 whatever the price does.
The model's one-paragraph read
Leans BUY — composite score +0.39 (BUY). Technicals: RSI 46.11, MACD bearish, price above SMA50. Fundamentals: PEG 10.00, margin 1.9%, revenue growth 12.8%. Financial results: YoY revenue +12.8%, last EPS surprise +800.0%, next earnings 2026-10-27. Smart Money Concepts: BOS bullish (trend continuation), price retesting a bearish order block. FinGPT news read: positive. Memory: 13 prior look(s); 45% of directional calls matched later price. Suggested levels: entry $56.44, target $64.01, stop-loss $51.24, exit by 2026-10-26 (exit before next earnings (2026-10-27) -- this signal doesn't price in that report).
Past ratings for ATRC
Of the last 10 directional calls on ATRC, 4 pointed the right way by the most recent analysis (40%). Past calls do not guarantee future results.
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Oct 13, 2026 | BUY | 39% | $57.28 | — | |
| Oct 12, 2026 | WEAK BUY | 13% | $55.81 | +2.6% | ✔ right direction |
| Oct 9, 2026 | WEAK BUY | 17% | $52.84 | +8.4% | ✔ right direction |
| Oct 1, 2026 | WEAK BUY | 16% | $54.40 | +5.3% | ✔ right direction |
| Sep 30, 2026 | WEAK BUY | 16% | $58.05 | -1.3% | ✘ wrong direction |
| Sep 29, 2026 | WEAK BUY | 17% | $58.41 | -1.9% | ✘ wrong direction |
| Sep 28, 2026 | WEAK BUY | 21% | $57.33 | -0.1% | ✘ wrong direction |
| Sep 24, 2026 | WEAK BUY | 16% | $59.96 | -4.5% | ✘ wrong direction |
| Sep 23, 2026 | WEAK BUY | 23% | $59.90 | -4.4% | ✘ wrong direction |
| Sep 18, 2026 | WEAK BUY | 19% | $58.91 | -2.8% | ✘ wrong direction |
| Sep 17, 2026 | SKIP | 1% | $58.48 | -2.1% | |
| Sep 16, 2026 | WEAK BUY | 25% | $57.13 | +0.3% | ✔ right direction |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
BCRX · BDX · BIIB · BMY · BSX · CNC · COO · CVS · DVA · EVH · FTRE · HALO
Frequently asked questions
Is ATRC a buy right now?
As of Oct 13, 2026, our automated model rates AtriCure, Inc. (ATRC) BUY with 39% confidence: most of the technical, fundamental, money-flow and news signals point to upside. This is a model output for education, not personal investment advice.
What is the price target for ATRC?
The model's most recent plan targets $64.01 with a stop-loss at $51.24, from an entry near $56.44.
When does AtriCure, Inc. report earnings next?
The next earnings report is expected around Oct 27, 2026.
What does a BUY rating mean?
A BUY rating means most of the technical, fundamental, money-flow and news signals point to upside.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.